What's New
Prescriber Update 47(2) June 2026
We've published the latest issue of Prescriber Update.
This issue contains information about adverse effects from inappropriate use of topical corticosteroids, undesirable effects of opioids, reported adverse reactions to ashwagandha, and more.
News and Events
| Date | Type | Title |
|---|---|---|
| 9/6/2026 | Notices | Adverse Reactions Reporting Webform will be temporarily unavailable from Tuesday 9 June 2026 5:00 pm to 10:00 pm. |
| 4/6/2026 | Media Release | Tighter controls on nitrous oxide come into force |
| 4/6/2026 | Publications | Prescriber Update Vol. 47. No. 2 - June 2026 |
| 21/5/2026 | Alert Communication | Consumer advisory: Unapproved peptide products health warning |
| 20/5/2026 | Notices | The verification pathway rules have been made |
| 20/5/2026 | Consultation | Outcome of Consultation on Verification Rules for New Medicine Applications (pdf 244 KB, 24 pages) |
| 24/4/2026 | Monitoring Communication | Further Update - Estradot (estradiol) transdermal patches: reports of quality and efficacy concerns |
